Tag Archive
Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug (News-Medical-Net)
Medivir AB (Sweden) today announced a license agreement with Daewoong Pharmaceutical Co. Ltd., (South Korea) for its hepatitis B virus (HBV) polymerase inhibitor drug, lagociclovir valactate (MIV-210). (read here…) Related items World’s first Cs-131 implant for colorectal cancer performed at Weill Cornell Medical Center (News-Medical-Net) OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva... »
HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia? (EurekAlert!)
( World Journal of Gastroenterology ) A research team from Indonesia identified the distribution of hepatitis B virus subgenotype and basal core promoter mutations among patients with HBV-associated liver disease in Indonesia. They found HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia. Mutations in BCP, such as A1762T/G1764A and T1753V, might... »
